Study of how well patients take hepatitis B medication with app support
Part of Digestive system, Infections clinical trials.
This study tests whether a smartphone app called HBVCare helps patients with chronic hepatitis B stick to their treatment plans. Researchers will track how well the app helps patients take their medicines on time and understand what makes treatment adherence easier or harder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have been diagnosed with chronic hepatitis B (confirmed by blood tests showing HBsAg or HBV DNA for at least 6 months)
- Own a smartphone (iPhone or Android) with working internet access and ability to download the HBVCare app
- Be able to read, understand, and respond to questions in Vietnamese
- Be willing to sign a consent form to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an intelligent smartphone app that helps people with hepatitis B start antiviral treatment. If you have been diagnosed but haven't started treatment, the app may guide you and your doctor in making that decision.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.